Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease. - Test2 - elhamkhani - TriplyDB

Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease.

Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease.

http://www.wikidata.org/entity/Q30525353

about

The role of oxidative stress in Parkinson's disease Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease Ageing and Parkinson's disease: why is advancing age the biggest risk factor?Upstream deregulation of calcium signaling in Parkinson's disease Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity Vagal determinants of exercise capacity.Soluble, prefibrillar α-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction.Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase.Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus Control of ventricular excitability by neurons of the dorsal motor nucleus of the vagus nerve.Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease The leak channel NALCN controls tonic firing and glycolytic sensitivity of substantia nigra pars reticulata neurons.Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington's Disease.Antioxidant gene therapy against neuronal cell death.The pathology roadmap in Parkinson disease.The control of brain mitochondrial energization by cytosolic calcium: the mitochondrial gas pedal.Parkinson's disease: an update on pathogenesis and treatment.Network modeling to identify new mechanisms and therapeutic targets for Parkinson's disease.Calcium signaling in Parkinson's disease.Interactions between calcium and alpha-synuclein in neurodegeneration.Redox imaging using genetically encoded redox indicators in zebrafish and mice.Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease.Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions.Measurement and meaning of cellular thiol:disufhide redox status.Calcium and Parkinson's disease.Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies.Selective neuronal vulnerability in Parkinson disease.ROS in Cancer: The Burning Question.The role of Ca2+ signaling in Parkinson's disease.Inhibition of L-Type Ca2+ Channels by TRPC1-STIM1 Complex Is Essential for the Protection of Dopaminergic Neurons.The inherent susceptibility of dorsal motor nucleus cholinergic neurons to the neurodegenerative process in Parkinson's Disease.Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins.The Multifaceted Roles of DJ-1 as an Antioxidant.Sex-Specific Consequences of Neonatal Stress on Cardio-Respiratory Inhibition Following Laryngeal Stimulation in Rat Pups.Parkinson's Disease Is Not Simply a Prion Disorder.Prying into the Prion Hypothesis for Parkinson's Disease.Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.

P2860

Q24307946-D17204C9-447E-40F0-8377-8DB3C1D3968D Q26853225-9137AA2F-660A-4E24-B40B-DA1726F1E126 Q27021628-796CE683-0036-4269-B1FB-F406FB113617 Q27026384-D0E8AE26-262D-4149-B4D6-CC1FF3066D49 Q28115890-644653D5-F570-4CD2-9A4A-E8F516B0D3D5 Q28854286-F3A35FA8-6CC2-42A8-896B-88DC3E687E96 Q30577415-A20B7AD8-B240-4226-9F67-4B9162B34A08 Q33753791-91430C5A-C303-4E93-897A-943839EED7B5 Q33985326-2CB482F7-216B-4534-80BB-66B267C08CCB Q34038937-11393043-43F2-4BA8-AC94-DF5D2323AB6F Q34371022-0DDA07C6-454B-4F4D-941D-DCCEDFFA42A0 Q35686569-FF77B60F-EDED-43F9-A7C0-381D56857F3F Q36245239-0209198E-E680-4FB6-9D4A-3A33B6DDDCB7 Q36511361-74DFF16C-5D3F-4ACA-AD57-A392CD7B512B Q36993657-A73F7DD3-C598-4271-9C7E-F0557DD4878E Q37507773-8B8A35CE-31E1-4023-9BB4-8122C53D4DB6 Q37647941-73DBBDDD-20BB-48C6-A095-554D177B5EDC Q38074519-F812213A-F90A-4C25-9A97-C2224D0C8563 Q38080810-C660C705-14AE-4398-8E7C-97B191A7994A Q38099279-5C33448B-FD3D-49A7-A08E-8C88DD243329 Q38112215-14DACAFA-616F-46E4-A95D-14648EBEACE3 Q38208179-E596BBC4-C1AE-49DF-A110-52EBCBB3B60C Q38254376-1E89E0DC-1723-44E4-8F71-9D359117D842 Q38365533-E15FCCA9-A520-4E0B-BABA-FD52F7E54C22 Q38502057-5DAE3AE6-BCB8-4304-9FAC-70E5DF62FF9E Q38610367-6704C84A-26A3-4704-9997-E0D90871631C Q38676671-41B19FED-294B-4FDF-A689-B24D03FF5BC4 Q38945252-CB1FECF3-73D5-45EE-9500-6427A4E5011A Q39075636-46469C0F-B710-47B3-80BE-A5F044B56D8E Q39095738-BF9F9658-9FCE-4E9D-882D-2D99F281E4F3 Q39253194-78E5B55F-5182-45E3-80B7-BBBEFBE997EC Q39281423-E925B363-A8CD-40B0-B107-D0FA411960EB Q41700351-F3974D07-1B0C-443E-B5A8-AA9674B6679C Q41923722-E5A599FE-3C7A-4870-BD78-F7329162A1CC Q44936401-4EEFDD89-0EF7-40F8-A8C7-4144A9BE3755 Q46259811-2F342BD4-276C-4544-BD64-251238869AA8 Q47130282-62828C6B-4CC1-4594-9884-5BFE2A2435B5 Q47314960-C64E7AD1-2158-4DE1-A691-2633C483EF7E Q47665674-05D6CCEB-6448-451E-99F7-C977D7EE94A5 Q48165108-B1DBFB30-7F9F-43F0-89C0-F6B69F57C1A8

P2860

Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease.

http://www.wikidata.org/entity/Q30525353

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Calcium entry induces mitochon ...... t risk in Parkinson's disease.

@ast

Calcium entry induces mitochon ...... t risk in Parkinson's disease.

@en

type

label

Calcium entry induces mitochon ...... t risk in Parkinson's disease.

@ast

Calcium entry induces mitochon ...... t risk in Parkinson's disease.

@en

prefLabel

Calcium entry induces mitochon ...... t risk in Parkinson's disease.

@ast

Calcium entry induces mitochon ...... t risk in Parkinson's disease.

@en

P1433

Q30525353-DBC0EF1A-2B7A-46B0-BDB7-D7B34839B6B6

P1476

Q30525353-1EA9D4D5-A413-498B-8E2B-D42A0A58305E

P2093

Q30525353-08E8D782-5B6E-4264-A602-ED875306B451

Q30525353-0CADA3DF-992E-4DC2-B276-645CD24B7344

Q30525353-5ED14878-B9BD-414C-A9AD-8B5506007DAF

Q30525353-77BC3DAF-6F33-4038-9D62-5F09F3EAE143

Q30525353-830E4B06-BC4C-481D-BF54-3EF8EFEFD4B4

Q30525353-A17BFFA4-B3E7-45FF-8399-413F3D625B5C

Q30525353-B04A7C05-A070-44AC-8F77-F0A2F7280C05

P2860

Q30525353-0945FA98-4F74-4088-9156-645D7FA317C9

Q30525353-09E57D66-221E-4780-86AA-151DDCD3FB55

Q30525353-0D4AF935-7A48-48F9-8654-CDF478CA0FE9

Q30525353-0ED1E962-BFCE-4C10-AA43-2F7DC86AAAED

Q30525353-1844EEC4-4162-46A7-8E99-F6CBBDE13376

Q30525353-22FC3679-3928-4112-96DE-9A4012B6E746

Q30525353-24519284-F5D3-47BD-AE6E-24AEB0974A94

Q30525353-276EB4A6-1B37-43FD-B9BD-3DB5BB02E9AE

Q30525353-284A5C6A-9B12-4733-97F1-D694C1182C10

Q30525353-3206AACF-63D4-464F-84E9-CC3E31C8492D

P2888

Q30525353-79E8FF96-D17A-4045-8C25-B6C1BC7618A2

P304

Q30525353-4AE52B51-A7A3-4A9F-BF48-2291ACF8CD49

P31

Q30525353-5856A827-24D1-4EA7-86D1-72063A94A9FA

P356

Q30525353-0FE6D8B1-3D97-4FBD-8C83-5BDB16EE9F53

P407

Q30525353-F82409E8-7351-449B-9198-26A62BD3CA29

P433

Q30525353-8960A0A9-966C-4B76-B35D-2624D54DA3C8

P478

Q30525353-F895DE90-CE4D-422F-91B6-4B6032242328

P577

Q30525353-2BD9B8C3-DDF6-4A46-B745-B9AD192CC142

P5875

Q30525353-47820184-6006-46F5-AA63-F8426F43FC53

P6179

Q30525353-D49A009F-6C14-482C-8457-6AABE1BA92A9

P698

Q30525353-1EDE2934-78B6-4016-9A52-F9C466F10E8A

P921

Q30525353-A579E32F-AB16-447F-9E79-10A6B3581B5E

P932

Q30525353-2E88A375-1539-4008-9756-C477CFFB8484

P356

P1433

Nature Neuroscience

P1476

Calcium entry induces mitochon ...... t risk in Parkinson's disease.

@en

P2093

Chad M Estep

http://www.w3.org/2001/XMLSchema#string

D James Surmeier

http://www.w3.org/2001/XMLSchema#string

Ema Ilijic

http://www.w3.org/2001/XMLSchema#string

Jaime N Guzman

http://www.w3.org/2001/XMLSchema#string

Javier Sanchez-Padilla

http://www.w3.org/2001/XMLSchema#string

Joshua A Goldberg

http://www.w3.org/2001/XMLSchema#string

Jyothisri Kondapalli

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.

The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm

Neuronal L-type calcium channels open quickly and are inhibited slowly

Epidemiology of Parkinson's disease

Stages in the development of Parkinson's disease-related pathology

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Parkinson's disease

Robust pacemaking in substantia nigra dopaminergic neurons.

L-type calcium channel blockers and Parkinson disease in Denmark.

Estimating intracellular calcium concentrations and buffering without wavelength ratioing.

P2888

P304

1414-1421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NN.3209

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230783350

http://www.w3.org/2001/XMLSchema#string

P6179

1017208185

http://www.w3.org/2001/XMLSchema#string

P698

22941107

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3461271

http://www.w3.org/2001/XMLSchema#string